1. Home
  2. BLTE vs EPAC Comparison

BLTE vs EPAC Comparison

Compare BLTE & EPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • EPAC
  • Stock Information
  • Founded
  • BLTE 2018
  • EPAC 1910
  • Country
  • BLTE United States
  • EPAC United States
  • Employees
  • BLTE N/A
  • EPAC N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • EPAC Industrial Machinery/Components
  • Sector
  • BLTE Health Care
  • EPAC Technology
  • Exchange
  • BLTE Nasdaq
  • EPAC Nasdaq
  • Market Cap
  • BLTE 2.1B
  • EPAC 2.2B
  • IPO Year
  • BLTE 2022
  • EPAC N/A
  • Fundamental
  • Price
  • BLTE $56.40
  • EPAC $38.50
  • Analyst Decision
  • BLTE Strong Buy
  • EPAC Buy
  • Analyst Count
  • BLTE 4
  • EPAC 1
  • Target Price
  • BLTE $96.67
  • EPAC $53.00
  • AVG Volume (30 Days)
  • BLTE 37.7K
  • EPAC 439.0K
  • Earning Date
  • BLTE 05-12-2025
  • EPAC 03-24-2025
  • Dividend Yield
  • BLTE N/A
  • EPAC 0.10%
  • EPS Growth
  • BLTE N/A
  • EPAC 35.24
  • EPS
  • BLTE N/A
  • EPAC 1.70
  • Revenue
  • BLTE N/A
  • EPAC $599,828,000.00
  • Revenue This Year
  • BLTE N/A
  • EPAC $7.32
  • Revenue Next Year
  • BLTE N/A
  • EPAC $6.79
  • P/E Ratio
  • BLTE N/A
  • EPAC $22.70
  • Revenue Growth
  • BLTE N/A
  • EPAC 0.43
  • 52 Week Low
  • BLTE $32.25
  • EPAC $34.64
  • 52 Week High
  • BLTE $86.53
  • EPAC $51.91
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 39.21
  • EPAC 37.89
  • Support Level
  • BLTE $49.00
  • EPAC $36.92
  • Resistance Level
  • BLTE $60.21
  • EPAC $40.74
  • Average True Range (ATR)
  • BLTE 3.55
  • EPAC 1.92
  • MACD
  • BLTE -0.57
  • EPAC -0.31
  • Stochastic Oscillator
  • BLTE 41.67
  • EPAC 16.61

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About EPAC Enerpac Tool Group Corp.

Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.

Share on Social Networks: